Skip to content
ApprovedFDA approved

Telmisartan (Micardis)

A prescription blood-pressure medicine (angiotensin receptor blocker) with the longest half-life in its class; not for use in pregnancy.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Telmisartan (Micardis) vial

DETAILED OVERVIEW

What is Telmisartan (Micardis)?

Telmisartan (Micardis) is a prescription blood-pressure medicine from the group called angiotensin receptor blockers. It blocks the action of angiotensin II, a hormone that narrows the blood vessels, so the vessels widen, the body excretes more sodium and blood pressure falls. It is approved for high blood pressure and for preventing cardiovascular events.

Its half-life is about 24 hours, the longest in its class, so its effect is long-lasting. It also partly activates a system that regulates fat cells and insulin sensitivity, which may be favourable for blood fats and sugar metabolism. In a study of more than 25,000 high-risk patients it was equivalent to the ACE inhibitor ramipril, with less cough. Giving the two together, however, brought no extra benefit, only more drops in blood pressure, fainting and kidney damage. It must not be used in pregnancy, because later on it can cause fetal kidney damage and death. It can raise potassium levels.

Mechanism

Blockade of the angiotensin II type 1 receptor: vasodilation and sodium excretion.

Half-life

~24 hours, the longest in the class; a missed dose does not upset control.

Metabolic extra

Partial stimulation of a metabolic receptor; may help sugar and fat metabolism

The ONTARGET lesson

Equivalent to ramipril and better tolerated; dual blockade, however, is harmful.

Bioavailability

About 42-58%, dose-dependent because first-pass metabolism is saturable.

Data console

Lab data

ATC code-
PrescriptionN/A
MechanismAngiotensin II is the main effector of the hormone system…
Half-life~24 hours, the longest among angiotensin receptor blockers, so the effect remains stable to the end of the interval with once-daily dosing.
OnsetThe antihypertensive effect appears within hours, but the full effect develops over four to eight weeks. The dose should therefore not be judged on a few days.
BioavailabilityAbout 42-58%, and dose-dependent: proportionally more is absorbed at higher doses because first-pass metabolism is saturable. Clearance occurs by glucuronidation with no meaningful involvement of the cytochrome P450 system, which means few drug interactions.

Safety

Side effects, stop signs, contraindications

Side effects · 3

  • Dizziness and low blood pressure, especially after the first doses, alongside a diuretic or in a volume-depleted state.
  • Rising serum potassium: inhibiting the renin-angiotensin system reduces potassium excretion. This can be clinically significant in renal disease, with a potassium-sparing diuretic or with potassium supplementation.
  • Declining renal function: with bilateral renal artery stenosis or severe volume depletion the drug impairs glomerular filtration. This is why creatinine and potassium should be checked after starting treatment.

Contraindications · 3

  • Pregnancy: an ABSOLUTE contraindication. Agents acting on the renin-angiotensin system cause fetal renal injury and death in the second and third trimesters; they must be switched before a planned pregnancy.
  • Concurrent ACE inhibitor or aliskiren: one of the key lessons of ONTARGET was precisely that dual blockade brings no added benefit but more adverse effects.
  • Bilateral renal artery stenosis, and severe hepatic or biliary obstruction.

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Telmisartan (Micardis)?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.